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Abstract
Little information is available on perinatal outcome of cryopreserved day-7 blastocyst transfer. In the present
report, perinatal outcomes for transfers of cryopreserved blastocysts by a vitrification method were examined
with respect to the day of blastocyst expansion among on day 5, 6 or 7 before cryopreservation. We investigated
263 cycles of vitrified-warmed blastocyst stage embryo transfer performed between April 2005 and April
2009, which were reviewed retrospectively. There were 144 cycles with day-5 blastocyst, 100 cycles with
day-6 blastocyst, and 19 cycles with day-7 blastocyst transfers. There were no differences among the vitrified
day-5, day-6 and day-7 blastocyst transfer groups regarding mean number of embryos transferred, pregnancy
rate, implantation rate and miscarriage rate. At this time, 71 deliveries have occurred with no reported abnor-
malities. There were 47 infants from 41 deliveries with day-5 blastocyst, 26 infants from 23 deliveries with
day-6 blastocyst, and 8 infants from 7 deliveries with day-7 blastocyst. There were no differences among the
three groups in the mean gestational age, preterm delivery rate and mean birth weight. These results indicated
that blastocysts have similar inherent viability regardless of whether they develop by day 5, 6 or 7.
 
Introduction
Previous investigators have suggested that the age of blas-
tocyst is indicative of embryo quality among human
embryos derived from assisted reproductive technology.
Superior pregnancy rates were reported with fresh transfer
occurring at day 5 as compared with day 6 [1–3]. How-
ever, blastocysts cryopreserved on day 5 have a pregnancy
potential similar to those of day-6 blastocysts [4,5]. These
results suggest that differences in pregnancy rate between
fresh and cryopreserved day-6 blastocysts attributed to
reduced embryo quality with slower development may
instead result from impaired endometrial receptivity by
the time more slowly growing embryos develop to the
stage at which implantation is possible. On the other hand,
little published information is available regarding the
transfer of day-7 blastocysts because embryos developing
slowly are generally considered nonviable and are there-
fore discarded. Case reports of both fresh and cryopre-
served embryo transfers have confirmed that day-7 blas-
tocysts may still be viable [6–8]. However, as far as is
known, studies evaluating the relationship between the
blastocyst age as late as on day 7 and embryo quality
(independent of the timing of endometrial receptivity) are
limited to a single report published by Richter et al. [9].
These authors evaluated the viability and implantation
potential of cryopreserved blastocysts by a slow-freezing
method according to the day of blastocyst expansion
among on day 5, 6 or 7 before cryopreservation. Addi-
tionally, little is available on perinatal outcome of cryo-
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npreserved day-7 blastocyst transfer. In the present report,
perinatal outcomes for transfers of cryopreserved blasto-
cysts by a vitrification method were examined with
respect to the day of blastocyst expansion among on day
5, 6 or 7 before cryopreservation.
Methods
Cycles of vitrified-warmed blastocyst stage embryo trans-
fer performed between April 2005 and April 2009 were
reviewed retrospectively. The treatment was conducted
with patients following informed consent. As the study
was retrospective, Institutional Review Board approval
was not required.
Women were treated with gonadotrophin-releasing hor-
mone (GnRH) analogue buserelin acetate (Mochida,
Tokyo, Japan) from either the preceding mid-luteal phase
in a long treatment protocol or second day of the cycle in
a short treatment protocol. Ovarian stimulation was car-
ried out with human menopausal gonadotrophin (Nikken,
Tokyo, Japan) or urinary FSH (Fertinorm; Serono, Japan).
Follicular development was monitored with serial (every
third day) vaginal ultrasound examinations and serum
oestradiol measurements. Human chorionic gonadotro-
phin (hCG; Teizo, Tokyo, Japan) was administered to
women when dominant follicles reached a diameter of
18mm. Oocytes were collected 35h after hCG adminis-
tration using a vaginal ultrasound-guided procedure and
were incubated in human tubal fluid (HTF) medium
(Irvine Scientific, CA, USA) containing 10% (v/v) serum
substitute supplement (SSS; Irvine). Sperm preparation
was carried out using discontinuous ISolate™ (Irvine)
gradient. Mature oocytes were either inseminated with
spermatozoa 5–7h after oocyte retrieval at a concentration
of 100,000 to 200,000 motile spermatozoa/ml for 5 to 10
oocytes or microinjected with a single spermatozoon. The
day of oocyte retrieval was defined as day 0. Fertilization
was confirmed at 24–25h after oocyte retrieval (day 1) by
the presence of two pronuclei. Fertilized oocytes were
transferred and cultured in Blast Assist Medium 1 (Med-
icult, Jyllinge, Denmark) until day 3, and then placed in
Blast Assist Medium 2 (Medicult) until day 5. On day 5,
the embryos were examined for development into blasto-
cysts and then placed in fresh Blast Assist Medium 2
(Medicult) until day 7. All oocytes and embryos were
incubated at 37 °C in an atmosphere of 6% CO2, 5% O2
and 89% N2.
Expanded blastocysts were vitrified on day 5, 6, or 7,
depending on day of expansion. For expanded blastocysts,
the development of the inner cell mass (ICM) and tro-
phectoderm was assessed. The ICM grading was as fol-
lows: A: tightly packed, many cells; B: loosely grouped,
several cells; C: very few cells. The trophectoderm grad-
ing was as follows: A: many cells forming a tightly knit
epithelium; B: few cells; C: very few cells forming a loose
epithelium [10]. Only expanded blastocysts scoring B or
higher both ICM and trophectoderm grades (i.e. BB) were
vitrified. The expanded blastocysts were vitrified by the
method developed by Kuwayama et al. [11] using a cryo-
top (Kitazato Supply Co., Fujinomiya, Japan), albeit with
slight modifications as described previously [5]. The cryo-
top consisted of a 0.4 mm wide × 20 mm long × 0.1 mm
thick polypropylene strip attached to a plastic handle and
equipped with a cover straw. As the base medium, modi-
fied HTF medium-HEPES (Irvine) plus 20% (v/v) SSS
(Irvine) was used. The equilibration solution contained
7.5% (v/v) ethylene glycol (Sigma Chemical Co., MO,
USA) and 7.5% (v/v) dimethyl sulphoxide (Kanto Chem-
ical Co., Tokyo, Japan). The vitrification solution was
composed of 15% (v/v) ethylene glycol, 15% (v/v)
dimethyl sulphoxide and 0.5 mol/l sucrose (Nacalai Tes-
que, Inc., Kyoto, Japan). Before starting the vitrification
procedure, artificial shrinkage of expanded blastocysts
was performed in the equilibration solution. First, pipet-
ting of the expanded blastocyst was started immediately
after placing the embryo in 1ml of 30°C equilibration sol-
ution with a glass pipette slightly smaller in diameter
(~140 μm) than the expanded blastocyst. After confirma-
tion of slight shrinkage of the blastocoele, pipetting was
performed with a pipette slightly smaller in diameter than
the first one (~100–120 μm). This procedure was repeated
two to three times until the blastocoele collapsed com-
pletely. After blastocoele contraction, the blastocysts were
equilibrated in the same equilibration solution for another
2min before exposure to the vitrification solution. The
blastocysts were then incubated in 1ml of 30°C vitrifica-
tion solution and loaded, within 45s onto the tip of the
cryotop with ~1 μl of cryoprotectant solution. Then the
cryotop was immediately submerged into liquid nitrogen
and under the liquid nitrogen the plastic cover was placed
over the strip to provide protection during storage.
The warming procedure was done as follows: The protec-
tive cover was removed in liquid nitrogen and the end of
the polypropylene strip was immersed directly into 1 ml
of 37°C 1.0 mol/l sucrose solution for 1 min. The blasto-
cysts were then transferred into 1 ml of 37°C 0.5 mol/l
sucrose solution for 3 min and washed twice in the base
medium for 5min. As soon as warming of blastocysts had
completed, assisted hatching was performed while the
warmed blastocysts remained collapsed (within 5min after
warming procedure completed) by the method as descri-
bed previously [12]. Briefly, embryos were placed under
mineral oil within a 50μl microdroplet of 37°C Sperm
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on a phase-contrast inverted microscope stage. Total
removal of the zona pellucida was performed using a laser
(Zilos-tk Laser, Hamilton Thorne Research, Beverly, MA,
USA) and mechanical pipetting. Embryos were stabilized
with a holding pipette held at 9 o’clock position, and posi-
tioned with the laser target located on the outer edge of the
zona. The power of laser was 100% and the pulse duration
was 500μs. By using this setting, a 10μm hole was formed
in the zona by a single laser application. Multiple irradi-
ations along the convex periphery of the zona from out-
ward to inward were used to form a 10μm opening. Sim-
ilarly, another opening was formed next to the initial one.
This procedure was repeated until a large opening was
formed in the zona. The size of the opening was 60-90%
of the circumference of the zona, estimated from an area
of empty perivitelline space. Approximately 2min per
embryo was required to complete the procedure. After
forming a large opening, the embryo was released from
the holding pipette and aspirated out from the opened zona
by mechanical pipetting, and the zona was removed. After
the assisted hatching procedure was completed, warmed
blastocysts were rinsed several times and were cultured in
Blast Assist Medium 2 (Medicult) for further culture until
transfer. The post-warming survival of blastocysts was
observed 1-2h after warming under a microscope, and re-
expanded blastocysts were judged to have survived.
Warmed blastocyst transfer was performed in hormonal
replacement treatment cycles. All women received trans-
dermal oestradiol (Estraderm 1.4-5.8 mg, Kissei, Tokyo,
Japan) with gonadotrophin-releasing hormone analogue
for the preparation of the endometrium. The administra-
tion of progesterone (vaginal 400mg daily) was initiated
when endometrial thickness exceeded 10 mm. Embryo
transfer was scheduled on day 5 after the initiation of pro-
gesterone treatment. The time from warming to transfer
ranged from 2-3h. One to two surviving blastocysts were
transferred into the patient’s uterus.
Analysis was restricted to cycles in which all transferred
embryos were vitrified on the same day of development,
and in which transfers were performed on the same day
on which embryos were warmed. For patients undergoing
multiple vitrified-warmed blastocyst transfer cycles dur-
ing the study period, only the first cycle was included in
the analysis. A clinical pregnancy was defined as a preg-
nancy when a gestational sac was recognized in the uterus
by ultrasound. The implantation rate was determined by
dividing the number of gestational sacs by the number of
embryos transferred.
The one-way ANOVA test, chi-squared test and Fisher’s
exact test were used as appropriate to determine statistical
differences among groups. A P-value of <0.05 was con-
sidered significant.
Results
Data were available for 263 cycles of vitrified-warmed
blastocyst transfer that fit the inclusion criteria. There
were 144 cycles with day-5 blastocyst, 100 cycles with
day-6 blastocyst, and 19 cycles with day-7 blastocyst
transfer. One to two blastocysts were warmed and trans-
ferred per cycle. Clinical pregnancies resulted from 140
(53.2%) of these treatment cycles.
Table 1 compares cycle characteristics according to the
day (after oocyte retrieval) of blastocyst vitrification.
There were no differences among the three groups in the
age of women at vitrification or warming, survival rate,
mean number of embryos transferred, implantation rate,
pregnancy rate and miscarriage rate.
A summary of perinatal outcome associated with these
treatment cycles is presented in Table 2. At this time, 71
deliveries have occurred with no reported abnormalities
(81 babies: 48 boys and 33 girls). There were 47 infants
from 41 deliveries with day-5 blastocyst, 26 infants from
Table 1.
Cycle characteristics and clinical outcomes as a function of day (after oocyte retrieval) on which blastocysts were
vitrified
Day of vitrification
  5
  6
  7
 
No. of cycles for warming 144 100 19
Mean age of women at vitrification
(years) ± SD
33.3 ± 4.7 33.7 ± 4.4 33.7 ± 3.7
Mean age of women at warming
(years) ± SD
34.2 ± 4.5 34.5 ± 4.3 35.0 ± 3.7
No. of blastocysts warmed 214 145 28
No. of blastocysts survived (%) 213 (99.5) 142 (97.9) 28 (100.0)
Mean no. of blastocysts transferred ±
SD
1.5 ± 0.5 1.4 ± 0.5 1.4 ± 0.5
No. of embryos implanted (%) 90 (42.3) 59 (41.5) 12 (42.9)
No. of clinical pregnancies (%) 77 (53.5) 53 (53.0) 10 (52.6)
No. of miscarriages (%) 18 (23.4) 16 (30.2) 3 (30.0)
No. of ongoing pregnancies 18 14 0
No. of deliveries
  41
  23
  7
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n23 deliveries with day-6 blastocyst, and 8 infants from 7
deliveries with day-7 blastocyst. There were no differen-
ces among the three groups in a ratio of male to female,
mean gestational age, preterm delivery rate and mean birth
weight.
During the period of this study, there were 10 cycles of
vitrified-warmed blastocyst transfer those were mix of
different days vitrified. In all 10 cycles, two blastocysts
were transferred, one on day 5 and one on day 6 vitrified.
A total of 20 (10 day-5 and 10 day-6) blastocysts were
vitrified and warmed. All 20 blastocysts (100%) survived
after warming and were transferred to 10 patients. The
pregnancy rate was 50% (5/10) and the implantation rate
was 30% (6/20). Of five pregnancies, one pregnancy
revealed two sacs and resulted in delivery of normal,
healthy male and female infants weighing 2,848 and 3,102
g at birth, at 35 weeks’ gestation. Another four pregnan-
cies were diagnosed as singletons. Of these, one preg-
nancy spontaneously aborted at 8 weeks of gestation, and
the other three pregnancies are ongoing.
Discussion
We previously reported 6 cases of successful pregnancy
(1 delivery, 2 abortions and 3 ongoing) following 11 trans-
fers of vitrified day-7 blastocyst [8]. The current series is
an extension of our earlier research and documents 10
cases of successful pregnancy (7 deliveries, 3 abortions)
and perinatal outcomes following 19 transfers of vitrified
day-7 blastocyst. As far as is known, this is the first pub-
lished assessment of perinatal outcomes for IVF patients
having transfers of vitrified day-5, day-6 and day-7 blas-
tocyst.
Richter et al. [9] observed a significantly lower pregnancy
rate with cryopreserved day-7 blastocyst transfers com-
pared with that obtained in cryopreserved day-5 and
day-6, but this difference was due, at least in part, to the
transfer of significantly fewer transferred day-7 blasto-
cysts, and was not statistically significant after accounting
for number of embryos per transfer. In the present report,
there were no differences among the vitrified day-5, day-6
and day-7 blastocyst transfer groups in the mean number
of embryos transferred, pregnancy rate, implantation rate
and miscarriage rate. We also compared the perinatal out-
come of vitrified day-5, day-6 and day-7 blastocyst trans-
fer groups. There were no differences among the three
groups in the mean gestational age, preterm delivery rate
and mean birth weight. These results indicated that blas-
tocysts have similar inherent viability regardless of
whether they develop by on day 5, 6 or 7.
The pregnancy rate of vitrified day-7 blastocyst transfers
of the present report (52.6%, 10/19) was significantly
higher than that of fresh day-7 blastocyst transfers of the
reports of Gorrill et al. (2001) [13] (4%, 1/25) and Utsu-
nomiya et al. [14] (10%, 3/31). In addition, Murata et al.
[15] reported significantly higher clinical pregnancy
results were obtained in cryopreserved day-6 blastocyst
transfers (55%, 22/40) compared with fresh day-6 blasto-
cyst replacements (11%, 4/37). Asynchrony with endo-
metrial receptively may therefore be responsible for
poorer success rates associated with the fresh transfers of
slower developing embryos. Embryo cryopreservation,
enabling more appropriate synchronization between
embryonic and endometrial development, may therefore
be an effective alternative to fresh embryo transfer or cycle
cancellation when blastocyst expansion is delayed until
day 6 or 7 after oocyte retrieval.
In conclusion, the results of the present study suggest that
vitrified human day-7 blastocyst transfer can contribute to
increasing cumulative pregnancy rates in assisted repro-
duction. However, it will require more data on vitrified
day-7 blastocyst transfer to determine the risk of sponta-
neous abortions and birth defects from these more slower
developing embryos. Until these data are collected and
analyzed, vitrified day-7 blastocyst transfer should be
approached with caution.
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